Pfizer Settles Conn. Zantac Lawsuits Alleging Cancer Risks
Pfizer Inc. has settled two Connecticut state court lawsuits by patients who claimed generic forms of ranitidine, the heartburn and acid reflux drug sold under the brand name Zantac, degraded into...To view the full article, register now.
Already a subscriber? Click here to view full article